Old Web
English
Sign In
Acemap
>
authorDetail
>
Aaron Fullerton
Aaron Fullerton
University of Colorado Boulder
Lenalidomide
Regimen
Internal medicine
Oncology
Febrile neutropenia
3
Papers
4
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Sequential azacitidine and lenalidomide for patients with relapsed and refractory acute myeloid leukemia: Clinical results and predictive modeling using computational analysis
2019
Leukemia Research
Brett M. Stevens
Amanda Winters
Jonathan A. Gutman
Aaron Fullerton
Gregory Hemenway
Derek Schatz
Nicholas Miltgen
Qi Wei
Taher Abbasi
Shireen Vali
Neeraj Kumar Singh
Leylah Drusbosky
Christopher R. Cogle
Andrew Hammes
Diana Abbott
Craig T. Jordan
Clayton A. Smith
Daniel A. Pollyea
Show All
Source
Cite
Save
Citations (4)
Sequential Azacitidine (Aza) and Lenalidomide (Len) for Patients (Pts) with Relapsed and Refractory (R/R) Acute Myeloid Leukemia (AML): Clinical Results and Predictive Modeling Using Computational Analysis and Serial Genomics
2017
Blood
Brett M. Stevens
Amanda Winters
Jonathan A. Gutman
Aaron Fullerton
Gregory Hemenway
Nicholas Miltgen
Qi Wei
Taher Abbasi
Shireen Vali
Neeraj Kumar Singh
Leylah M. Drusbosky
Christopher R. Cogle
Andrew Hammes
Craig T. Jordan
Daniel A. Pollyea
Show All
Source
Cite
Save
Citations (0)
Sequential Azacitidine and High-Dose Lenalidomide for Relapsed and Refractory High-Risk MDS and AML: Interim Analysis of a Phase 2 Study
2014
Blood
Daniel A. Pollyea
Clayton A. Smith
Vu H. Nguyen
Aaron Fullerton
Derek Schatz
Edward J. Bedrick
Jonathan A. Gutman
Show All
Source
Cite
Save
Citations (0)
1